Tomas Sveger

3.6k total citations · 1 hit paper
79 papers, 2.5k citations indexed

About

Tomas Sveger is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Tomas Sveger has authored 79 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 22 papers in Pediatrics, Perinatology and Child Health and 18 papers in Surgery. Recurrent topics in Tomas Sveger's work include Protease and Inhibitor Mechanisms (16 papers), Neonatal Respiratory Health Research (13 papers) and Childhood Cancer Survivors' Quality of Life (9 papers). Tomas Sveger is often cited by papers focused on Protease and Inhibitor Mechanisms (16 papers), Neonatal Respiratory Health Research (13 papers) and Childhood Cancer Survivors' Quality of Life (9 papers). Tomas Sveger collaborates with scholars based in Sweden, Netherlands and United States. Tomas Sveger's co-authors include Thomas Thelin, Eeva Piitulainen, Sten Eriksson, Carl-Erik Flodmark, Olof Rydén, T. F. McNeil, P. Nilsson–Ehle, C.‐B. Laurell, M Arborelius and Thomas F. McNeil and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Tomas Sveger

79 papers receiving 2.4k citations

Hit Papers

Liver Disease in Alpha1-Antitrypsin Deficiency Detected b... 1976 2026 1992 2009 1976 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Sveger Sweden 26 907 699 462 461 356 79 2.5k
Thomas Wiebe Sweden 30 217 0.2× 547 0.8× 308 0.7× 1.0k 2.2× 443 1.2× 115 2.9k
Antônio Sérgio Petrilli Brazil 27 275 0.3× 715 1.0× 157 0.3× 752 1.6× 306 0.9× 121 2.4k
Jerry Stein Israel 27 135 0.1× 298 0.4× 793 1.7× 177 0.4× 282 0.8× 119 2.3k
Bettina Tóth Germany 37 269 0.3× 278 0.4× 404 0.9× 193 0.4× 152 0.4× 192 4.1k
Sita H. Vermeulen Netherlands 28 268 0.3× 142 0.2× 462 1.0× 156 0.3× 454 1.3× 77 2.8k
Riitta Koistinen Finland 41 252 0.3× 330 0.5× 105 0.2× 201 0.4× 338 0.9× 103 4.7k
Kenichi Ishizawa Japan 30 134 0.1× 993 1.4× 377 0.8× 317 0.7× 326 0.9× 211 3.5k
Maria Moschovi Greece 23 131 0.1× 427 0.6× 297 0.6× 219 0.5× 161 0.5× 104 1.9k
Elizabeth A. Tindall United States 19 159 0.2× 371 0.5× 659 1.4× 170 0.4× 268 0.8× 35 3.3k
Peter Rubin United States 24 147 0.2× 678 1.0× 142 0.3× 230 0.5× 543 1.5× 65 2.6k

Countries citing papers authored by Tomas Sveger

Since Specialization
Citations

This map shows the geographic impact of Tomas Sveger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Sveger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Sveger more than expected).

Fields of papers citing papers by Tomas Sveger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Sveger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Sveger. The network helps show where Tomas Sveger may publish in the future.

Co-authorship network of co-authors of Tomas Sveger

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Sveger. A scholar is included among the top collaborators of Tomas Sveger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Sveger. Tomas Sveger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanash, Hanan, et al.. (2015). The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34. Annals of the American Thoracic Society. 12(6). 807–812. 19 indexed citations
2.
Díaz, Sandra, et al.. (2010). CT lung densitometry in young adults with alpha-1-antitrypsin deficiency. Respiratory Medicine. 105(1). 74–79. 8 indexed citations
3.
Wollmer, Per, et al.. (2009). Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals. Respiratory Medicine. 103(6). 861–865. 15 indexed citations
4.
Lāce, Baiba, et al.. (2008). Age of SERPINA1 Gene PI Z Mutation: Swedish and Latvian Population Analysis. Annals of Human Genetics. 72(3). 300–304. 18 indexed citations
5.
Novoradovskaya, Natalia, et al.. (2008). Endotoxin receptor CD14 in PiZ α-1-antitrypsin deficiency individuals. Respiratory Research. 9(1). 34–34. 9 indexed citations
6.
Åstrand, Ramona, et al.. (2007). Haemophilus meningitis in a six-month-old boy vaccinated against Hib. Scandinavian Journal of Infectious Diseases. 39(8). 743–744. 1 indexed citations
7.
Sveger, Tomas, et al.. (2007). Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency. Respiratory Medicine. 101(9). 1971–1976. 34 indexed citations
9.
Sveger, Tomas, K. Ohlsson, Helena Mörse, Staffan Polberger, & S. Laurin. (2003). Plasma neutrophil lipocalin, elastase‐α 1 ‐antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scandinavian Journal of Clinical and Laboratory Investigation. 63(2). 89–92. 12 indexed citations
10.
Bredberg, Anders, et al.. (2002). A longitudinal cohort study on the prevalence of Helicobacter pylori antibodies in Swedish children and adolescents. Acta Paediatrica. 91(6). 636–640. 13 indexed citations
11.
Sveger, Tomas, et al.. (1998). Adolescents with α1-Antitrypsin Deficiency Have High α2-Macroglobulin and Low Neutrophil Lipocalin and Elastase Levels in Plasma. Pediatric Research. 44(6). 939–941. 15 indexed citations
12.
Johansson, Peter, et al.. (1996). Reovirus Type 1 Associated with Meningitis. Scandinavian Journal of Infectious Diseases. 28(2). 117–120. 37 indexed citations
13.
Sveger, Tomas, Eeva Piitulainen, & M Arborelius. (1995). Clinical features and lung function in 18‐year‐old adolescents with α1‐antitrypsin deficiency. Acta Paediatrica. 84(7). 815–816. 21 indexed citations
14.
Sveger, Tomas & Sten Eriksson. (1995). The liver in adolescents with α-antitrypsin deficiency. Hepatology. 22(2). 514–517. 146 indexed citations
15.
Sveger, Tomas. (1994). Screening for alpha1‐antitrypsin deficiency. Acta Paediatrica. 83(s393). 18–20. 11 indexed citations
16.
Sveger, Tomas, et al.. (1989). Apolipoproteins A‐I and B in Obese Children. Journal of Pediatric Gastroenterology and Nutrition. 9(4). 497–501. 1 indexed citations
17.
Sveger, Tomas, et al.. (1989). Apolipoproteins A-I and B in Obese Children. Journal of Pediatric Gastroenterology and Nutrition. 9(4). 497–501. 13 indexed citations
18.
Sveger, Tomas. (1988). The Natural History of Liver Disease in (α1‐Antitrypsin Deficient Children. Acta Paediatrica. 77(6). 847–851. 174 indexed citations
19.
McNeil, T. F., Tomas Sveger, & Thomas Thelin. (1988). Psychosocial effects of screening for somatic risk: the Swedish alpha 1 antitrypsin experience.. Thorax. 43(7). 505–507. 31 indexed citations
20.
Sveger, Tomas. (1984). Prospective study of children with α1-antitrypsin deficiency: Eight-year-old follow-up. The Journal of Pediatrics. 104(1). 91–94. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026